Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Net Sales
34.08
18.73
Other Operating Income
0.00
0.00
Total Operating income
34.08
18.73
Raw Material Cost
30.09
16.05
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-2.54
0.00
Employee Cost
2.33
0.64
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
1.38
0.88
Total Expenditure (Excl Depreciation)
31.26
17.57
Operating Profit (PBDIT) excl Other Income
2.82
1.16
Other Income
0.03
0.19
Operating Profit (PBDIT)
2.85
1.35
Interest
0.93
0.43
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
1.92
0.92
Depreciation
0.73
0.59
Profit Before Tax
1.19
0.33
Tax
0.24
0.07
Provisions and contingencies
0.00
0.00
Profit After Tax
0.95
0.26
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
0.95
0.26
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
0.95
0.26
Equity Capital
12.00
3.00
Face Value
10.0
10.0
Reserves
0.00
0.00
Earnings per share (EPS)
0.79
0.3
Diluted Earnings per share
0.43
0.86
Operating Profit Margin (Excl OI)
8.27%
6.19%
Gross Profit Margin
5.63%
4.91%
PAT Margin
2.79%
1.39%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 47.08%
Standalone Net Profit
YoY Growth in year ended Mar 2024 is -35.00%
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is -37.04%
Interest
YoY Growth in year ended Mar 2024 is 0.00%
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
Compare Annual Results Of Bandaram Pharma With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
34.08
0
34.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
34.08
0
34.08
Raw Material Cost
30.09
0
30.09
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-2.54
0
-2.54
Employee Cost
2.33
0
2.33
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
1.38
0.00
1.38
Total Expenditure (Excl Depreciation)
31.26
0
31.26
Operating Profit (PBDIT) excl Other Income
2.82
0.00
2.82
Other Income
0.03
0
0.03
Operating Profit (PBDIT)
2.85
0
2.85
Interest
0.93
0
0.93
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1.92
0
1.92
Depreciation
0.73
0
0.73
Profit Before Tax
1.19
0
1.19
Tax
0.24
0
0.24
Provisions and contingencies
0.00
0
0.00
Profit After Tax
0.95
0
0.95
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
0.95
0
0.95
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
0.95
0
0.95
Equity Capital
12.00
0
12.00
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.79
0
0.79
Diluted Earnings per share
0.43
0
0.43
Operating Profit Margin (Excl OI)
8.27%
0%
0.00
8.27%
Gross Profit Margin
5.63%
0%
0.00
5.63%
PAT Margin
2.79%
0%
0.00
2.79%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 14.84 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 47.08%
Annual - Standalone Net Profit
Standalone Net Profit 0.13 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -35.00%
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.17 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -37.04%
Annual - Interest
Interest 0.00 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 0.00%
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.15%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
